Open Access

Psychiatric comorbidities and photophobia in patients with migraine

The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201718:18

DOI: 10.1186/s10194-017-0718-1

Received: 24 October 2016

Accepted: 5 January 2017

Published: 9 February 2017

The Erratum to this article has been published in The Journal of Headache and Pain 2017 18:33

Abstract

Background

Based on recent findings and our own impressions we took a closer look at the relationship between (inter)ictal photophobia and psychometric variables in migraine patients with photophobia.

Findings

For this study we included 29 (27 female) migraine patients and 31 (18 female) controls with a mean age of 31.6 ± 12.5 years and 24.0 ± 4.1 years, respectively. All participants filled out the Depression Anxiety Stress Scale (DASS).

Interictal photophobia in patients was significantly higher than photophobia in controls (p = .001). Patients showed statistically significantly higher levels of depressive symptoms (p < .001), anxiety symptoms (p < .001) and stress (p < .001) than controls. Among all participants, (interictal) photophobia correlated positively with age (rho = .318, p = .013) as well as with the levels of depressive symptoms (rho = .459, p < .001), anxiety symptoms (rho = .346, p = .008) and stress (rho = .368, p = .005), but not with gender. In the patients, ictal photophobia correlated positively with age (rho = .473, p = .01) and interictal photophobia (rho = .423, p = .022). Linear regression analysis revealed only a trend towards statistical significance for (interictal) photophobia as a predictor for the level of depressive symptoms (rho = .457, p = 0.056) in the whole sample.

Conclusions

Considering higher levels of photophobia in depression and the comorbidity of migraine and depression, it might be possible that depression contributes to interictal photophobia in patients with migraine. The same may be true for anxiety and stress. Both are also related to migraine and their possible impact on photophobia in migraine may be explained by pupillary dysfunction.

Keywords

Migraine Photophobia Depression Anxiety Stress

Introduction

Photophobia is a common symptom of migraine attacks experienced by up to 80% of the patients. The prevalence seems to increase with age [13]. Sensitivity to light is not limited to the headache phase, but frequently is also present in the premonitory phase as well as after headache has subsided [1]. Measuring quantitative thresholds for discomfort and pain with monocular and binocular light stimuli, Vanagaite et al. [4] found that migraine patients were more photophobic during attacks than outside attacks and that they were more sensitive to light than controls even between attacks. Main et al. [5] reported significantly lower interictal light discomfort thresholds in migraineurs compared to controls. Functional neuroimaging showed more activation of the extrastriate visual cortex in migraine patients with photophobia compared to those without photophobia during the premonitory phase of a migraine attack [6, 7].

The comorbidity of migraine with depression, anxiety and stress is well known and was investigated recently in a population-based study by Risal et al. which highlighted the negative consequences of these co-morbidities on the quality of life in migraine patients [8]. In this context it appears noteworthy that patients with psychiatric disorders often exhibit affective temperament dysregulation and suicidal behaviors [9]. These specific characteristics may significantly contribute to the psychocial impairment and altered quality of life of these subjects. A possible relation between depression and photophobia has been reported already in 1989 [10]. Recently Llop et al. [11] and Anagnostou et al. [12] investigated the association of migraine and photophobia. While the former authors [11] found that photophobia might predispose migraineurs for psychiatric comorbidities, the latter showed that photophobia may not exclusively be related to migraine [12].

During the patient recruitment for a case-control functional magnetic resonance imaging (fMRI) study on the effects of repeated flicker light exposure on photophobia in migraine patients (KLI 455, Austrian Science Fund, FWF) we noticed that the number of patients with significant psychiatric comorbidities exceeded our expectations.

Hence, we decided to take a closer look at the relationship between (inter)ictal photophobia and psychometric variables in the subjects screened for participation in our fMRI study.

Findings

We included patients with migraine and migraine-free controls screened for possible participation in a prospective study on the effects of repeated flicker light exposure on the level of photophobia (KLI 455, Austrian Science Funds (FWF)).

The participants’ age had to be between 18 to 45 years. Inclusion criteria for patients comprised (1) migraine without aura according to the criteria of the beta-version of the third edition of the International Classification of Headache Disorders (ICHD-3 beta) [13], (2) 1–4 days with migraine per month in the 3 months preceding study inclusion, (3) an intensity of interictal photophobia of 2–6 on a numeric rating scale (NRS, range 0 to 10) and (4) an intensity of ictal photophobia of >4. Controls had to fulfil the following inclusion criteria: (1) no personal or family history of migraine and (2) photophobia <2 on the NRS. Exclusion criteria for both groups were: (1) any other recurrent current or previous headache disorder apart from infrequent tension-type headache, and (2) current or previous medication overuse. All participants completed the 21-item version of the Depression Anxiety Stress Scale (DASS) [14]. It consists of three self-report scales (7 items per scale) designed to measure the negative emotional states of depression, anxiety and stress. The depression scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest/involvement, anhedonia, and inertia. The anxiety scale assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic non-specific arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset/agitated, irritable/over-reactive and impatient. Subjects are asked to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items. Paricipants were excluded from the flicker light study, if the DASS depression subscore was ≥7 points and/or the anxiety subscore was ≥6 points.

So far, we have screened 29 (27 female) migraine patients and 31 (18 female) controls (p = .005) with a mean age of 31.6 ± 12.5 years and 24.0 ± 4.1 years (p = .74), respectively. We were astounded that 10 (40%) migraine patients had to be excluded from the flicker light study, because the DASS depression subscore was ≥7 and/or the anxiety subscore was ≥6, while none of the controls exceded these cut-off scores (p < 0.001).

Interictal photophobia was <2, 2–6, and >6 in 7, 19, and 3 patients; ictal photopobia was ≤4 in 1 and >4 28 patients. Ten controls gave photophobia ≥2. Interictal photophobia in patients was significantly higher than photophobia in controls (Table 1, p = .001). Patients and controls also differed statistically significantly regarding their levels of depressive symptoms (p < .001), anxiety symptoms (p < .001) and stress (p < .001) on the DASS (Table 1).
Table 1

Clinical data of migraine patients and controls

  

Patients (n = 29)

Controls (n = 31)

p-value

Age

mean ± SD

31.6 ± 12.5

24.0 ± 4.1

.74

range

19–68

20–29

 

Gender (m:f)

n

2:27

12:18

.005*

(Interictal) photophobia (NRS)

mean ± SD

3.1 ± 2.1

1.5 ± 1.8

.001+

range

0–8

0–7

 

Ictal photophobia (NRS)

mean ± SD

7.3 ± 1.8

N/A

range

3–7

N/A

 

DASS depression score

mean ± SD

3.6 ± 4.0

0.7 ± 1.1

<.001+

range

0–15

0–5

 

DASS anxiety score

mean ± SD

4.0 ± 4.0

0.4 ± 0.8

<.001+

range

0–14

0–3

 

DASS stress sore

mean ± SD

6.0 ± 5.2

1.4 ± 1.9

<.001+

range

0–19

0–7

 

DASS Depression Anxiety Stress Scale, N/A not applicable, NRS numeric rating scale, SD standard deviation. +Mann-Whitney-U-test; *Chi-Quadrat-test

To further evaluate the impact of photophobia we performed multivariate correlation analyses including age, gender and DASS scores of depressive symptoms, anxiety symptoms and stress as well as linear regression analyses using each of the three psychiatric domains as dependent variables. Both calculations were done for the entire sample of participants (n = 60) and separately for patients with migraine (n = 29) and controls (n = 31).

Among all participants, (interictal) photophobia correlated positively with age (rho = .318, p = .013) as well as with the DASS subscores for depressive symptoms (rho = .459, p < .001), anxiety symptoms (rho = .346, p = .008) and stress (rho = .368, p = .005), but not with gender. In the patients, the only statistically significant correlations were those of ictal photophobia with age (rho = .473, p = .01) and interictal photophobia (rho = .423, p = .022). Ictal photophobia did not correlate with gender and DASS scores. Interictal photophobia did not show any statistically significant correlations in patients and the same was true for photophobia in controls.

Linear regression analysis revealed only a trend towards statistical significance for (interictal) photophobia as a predictor for the level of depressive symptoms (rho = .457, p = 0.056) in the whole sample. In separate analyses of patients and controls, none of the factors age, gender, (interictal) photophobia and ictal photophobia (for migraine patients only) significantly predicted the levels of depressive symptoms, anxiety symptoms and stress.

Discussion

This analysis of 60 subjects screened for participation in a prospective study on the effects of repeated flicker light exposure on the level of photophobia revealed a trend towards a relation of photophobia to the severity of depressive symptoms, anxiety symptoms and stress. However, this was only true for the total group of migraine patients and controls and not for each of the two study groups separately.

Accordingly, we failed to replicate the findings of Llop et al. [11]. These authors applied the Beck Depression Inventory (BDI-II) and the Beck Anxiety Inventory (BAI) in migraine patients with and without interictal photophobia and in migraine-free controls and included 16 subjects in each of the three groups. BDI-II and BAI scores were statistically significantly higher in patients with interictal photophobia than in those without interictal photophobia and in migraine-free controls.

The conflicting findings in our study and that of Llop and co-workers [11] may be explained by the different questionnaires (DASS vs. BDI-II and BAI) and by differences in age (31.6 vs 51 years). The latter might be more relevant following the hypothesis of Llop et al. [11] that interictal photophobia may increase with age as part of a central sensitization process. Similarly Grassini and Nordin [15] hypothesized the central sensitization may explain depression, anxiety, stress, functional somatic syndromes, and somatization in patients with migraine.

Considering higher levels of photophobia in depression [16] and the comorbidity of migraine and depression [17], it might be possible that depression contributes to interictal photophobia in patients with migraine. The same may be true for anxiety and stress. Both are also related to migraine [18] and their possible impact on photophobia in migraine may be explained by pupillary dysfunction [1820]. In anxiety disorders [18, 19] and posttraumatic stress disorder [20] exaggerated pupillary dilation in response to stressful and negative stimuli is a reliable autonomous marker, even beyond the clinically active phase of the condition [20]. In contrast, a most recent abstract [21] showed a sympathetically-mediated association between interictal photophobia and pupil size in patients with migraine. In this study, lower photophobia thresholds were related to smaller dark-adapted pupil size and impaired re-dilation following a brief pulse of light. Re-dilation was least pronounced in the most severely affected patients. These findings suggest a physiological coping mechanism to a lowered threshold for light sensitivity in patients with migraine. Recently, prolonged neuronal suppression after visual adaptation in migraine patients has been reported [22]. One may speculate that pupillary dilation related to anxiety and stress counteracts this coping mechanism and thus causes increased photophobia. Finally, tizanidine, a drug used in migraine prophylaxis, has been shown to reduce pain-induced pupillary dilation [23], but the effect of tizanidine on photophobia in migraine has not been assessed.

Our study is limited by the small sample size emphasizing the preliminary and exploratory nature of our main findings. It may also have been biased by the predominance of the female gender in the patient group compared to the controls. The inclusion of another control group consisting of migraine patients without interictal photophobia would have further strengthened our data.

In conclusion, the relation of photophobia, pupillary function, and psychiatric comorbidities in patients with migraine is not well understood and deserves further and larger studies.

Notes

Abbreviations

DASS: 

Depression Anxiety Stress Scale

fMRI: 

functional magnetic resonance imaging

ICHD: 

International Classification of Headache Disorders

NRS: 

Numeric rating scale

Declarations

Acknowledgement

The data presented are part of a study funded by FWF (KLIF 455, Austrian Science Fund).

Authors’ contributions

SS contributed to conception and design of the study, performed the analysis of the data and drafted the manuscript. RB contributed to conception and design of the study. MM and TSA contributed to the design of the study and performed the data acquisition. CW contributed to conception and design of the study and to analysis and interpretation of data and revised the manuscript critically. All authors read and approved the final manuscript.

Competing interests

Christian Wöber has received personal fees from St. Jude, Allergan, Pfizer and Apomedica and is paid consultant to Curelator. Stefan Seidel has received personal fees from UCB Pharma. Roland Beisteiner, Maike Manecke and Tuna Stefan Aslan declare no competing financial interest.

Ethics approval and consent to participate

Written consent was obtained from each participant and the study protocol was approved by the Ethics Committee of the Medical University of Vienna.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Neurology, Medical University of Vienna

References

  1. Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al (2003) Premonitory symptoms in migraine: an electronic diary study. Neurology 60:935–940View ArticlePubMedGoogle Scholar
  2. Kelman L (2006) Migraine changes with age: IMPACT on migraine classification. Headache 46:1161–1171View ArticlePubMedGoogle Scholar
  3. Wöber-Bingöl C, Wöber C, Karwautz A, Auterith A, Serim M, Zebenholzer K et al (2004) Clinical features of migraine: a cross-sectional study in patients aged three to sixty-nine. Cephalalgia 24:12–17View ArticlePubMedGoogle Scholar
  4. Vanagaite J, Pareja JA, Storen O, White LR, Sand T, Stovner LJ (1997) Light-induced discomfort and pain in migraine. Cephalalgia 17:733–741View ArticlePubMedGoogle Scholar
  5. Main A, Dowson A, Gross M (1997) Photophobia and phonophobia in migraineurs between attacks. Headache 37:492–495View ArticlePubMedGoogle Scholar
  6. Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ (2015) The premonitory phase of migraine--what can we learn from it? Headache 55:609–620View ArticlePubMedGoogle Scholar
  7. Maniyar FH, Sprenger T, Shankin CJ, Goadsby PJ (2014) Photic hypersensitivity in the premonitory phase of migraine – a positron emission tomography study. Eur J Neurol 21:1178–1183View ArticlePubMedGoogle Scholar
  8. Risal A, Manandhar K, Holen A, Steiner TJ, Linde M (2016) Comorbidities of psychiatric and headache disorders in Nepal: implications from a nationwide population-based study. J Headache Pain 17:45View ArticlePubMedPubMed CentralGoogle Scholar
  9. Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N, Negro A, Simmaco M, Girardi P, Martelletti P (2012) Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci 16:1389–1398PubMedGoogle Scholar
  10. Signer SF, Lapierre YD (1989) Photophobia in depression. Am J Psychiatry 146:1355–1356View ArticlePubMedGoogle Scholar
  11. Llop S, Frandsen JE, Digre KB, Katz BJ, Crum AV, Zang C, Warnger JEA (2016) Increased prevalence of depression and anxiety in patients with migraine and interictal photophobia. J Headache Pain 17:34View ArticlePubMedPubMed CentralGoogle Scholar
  12. Anagnostou E, Vikelis M, Tzavellas E, Ghika A, Kouzi I, Evdokimidis I, Kararizou E (2016) Photophobia in primary headaches, in essential blepharospasm and in major depression. Int J Neurosci 13:1–7View ArticleGoogle Scholar
  13. Headache Classification Committee of the International Headache Society (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808View ArticleGoogle Scholar
  14. Lovibond PF, Lovibond SH (1995) The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 33:335–343View ArticlePubMedGoogle Scholar
  15. Grassini S, Nordin S (2015) Comorbidity in migraine with functional somatic syndromes, psychiatric disorders and inflammatory diseases: a matter of central sensitization? Behav Med 1–9. [Epub]
  16. Seggie J, Canny C, Mai F, McCrank E, Waring E (1989) Antidepressant medication reverses increased sensitivity to light in depression: preliminary report. Prog Neuropsychopharmacol Biol Psychiatry 13:537–541View ArticlePubMedGoogle Scholar
  17. Minen MT, De Dahem OB, Van Diest AK, Power S, Schwedt TJ, Lipton R, Silbersweig D (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87:741–749View ArticlePubMedGoogle Scholar
  18. Bakes A, Bradshaw CM, Szabadi E (1990) Attenuation of the pupillary light reflex in anxious patients. Br J Clin Pharmacol 30:377–381View ArticlePubMedPubMed CentralGoogle Scholar
  19. Kojima M, Shioiri T, Hosoki T, Kitamura H, Bando T, Someya T (2004) Pupillary light reflex in panic disorder. A trial using audiovisual stimulation. Eur Arch Psychiatry Clin Neurosci 254:242–244View ArticlePubMedGoogle Scholar
  20. Cascardi M, Armstrong D, Chung L, Paré D (2015) Pupil response to threat in trauma-exposed individuals with or without PTSD. J Trauma Stress 28:370–374. doi:10.1002/jts.22022, Epub 2015 Jul 27View ArticlePubMedPubMed CentralGoogle Scholar
  21. Cortez M, Rea N, Hunter L, Digre K, Brennan K (2016) Altered pupillary light responses in migrainous photophobia. OR1. doi:10.1111/head.12832
  22. Shepherd AJ, Joly-Mascheroni RM (2016) Visual motion processing in migraine: enhanced motion after-effects are related to display contrast, visual symptoms, visual triggers and attack frequency. Cephalalgia. [Epub ahead of print]
  23. Chapman CR, Bradshaw DH, Donaldson GW, Jacobson RC, Nakamura Y (2014) Central noradrenergic mechanisms and the acute stress response during painful stimulation. J Psychopharmacol 28:1135–1142View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017